🇺🇸 FDA
Pipeline program

Jaypirca 100 mg film-coated tablets, BGB-16673, BGB-16673

BGB-16673-304

Phase 3 small_molecule active

Quick answer

Jaypirca 100 mg film-coated tablets, BGB-16673, BGB-16673 for Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL) is a Phase 3 program (small_molecule) at Beone Medicines Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Beone Medicines Ireland Limited
Indication
Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials